1. Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP

2. 2/15 Division of Bacterial, Parasitic and Allergenic Products (DBPAP) Merger (1999) of Division of Bacterial Products (DBP) and Division of Allergenic Products and Parasitology (DAPP) Leadership Drusilla Burns, PhD (Acting) 1999-2000 Richard Walker, PhD 2000-2008 Milan Blake, PhD 2008-2010 Jay Slater, MD 2010-present

3. 3/15 Division of Bacterial, Parasitic and Allergenic Products (DBPAP) Immediate Office of the Director Jay Slater, MD – Director Drusilla Burns, PhD – Deputy Director (Acting) Regulatory Staff Jennifer Bridgewater – Assoc. Dir. Regulatory Policy Tina Roecklein – Regulatory Coordinator 5 FTE Laboratory of Respiratory and Special Pathogens Drusilla Burns, PhD - Chief Juan Arciniega, D Sci James Keller, PhD Tod Merkel, PhD Michael Schmitt, PhD 16 FTE, 7 ORISE Laboratory of Bacterial Polysaccharides Willie Vann, PhD – Chief Mustafa Akkoyunlu, PhD Margaret Bash, MD Wei Wang, PhD John Cipollo, PhD Daron Freedberg, PhD 16 FTE, 11 ORISE Laboratory of Enteric and Sexually Transmitted Diseases Scott Stibitz, Ph.D. – Chief Dennis Kopecko, PhD 7 FTE, 13 ORISE Laboratory of Mycobacterial Diseases & Cellular Immunology Sheldon Morris, Ph.D. – Chief Siobhan Cowley, PhD Karen Elkins, PhD 10 FTE, 9 ORISE As of 15 April 2011 Laboratory of Immunobiochemisty Ron Rabin, M.D. – Chief 9 FTE, 7 ORISE

4. 4/15 DBPAP regulatory/research portfolio Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

5. 5/15 DBPAP regulatory/research portfolio Bacterial Polysaccharides (LBP) Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

6. 6/15 Bacterial polysaccharides (LBP) Akkoyunlu Regulation of humoral immune response against polysaccharide vaccines by bacterial products Bash To present protein targets as alternatives based on molecular epidemiology of the pathogen where polysaccharide vaccines have lacked success Cipollo Mass spectrometry of carbohydrates as a tool for characterization of bacterial vaccines and pathogens Freedberg Improvement of biological product quality by application of new technologies to characterize of vaccines and blood products: NMR spectroscopy and light scattering Vann To detemine the metabolic pathway for the synthesis of polysaccharides in gram negative pathogens and to use this knowledge to development methods for preparing glycoconjugate vaccines using metabolic engineering To improve and understand the manufacture of current conjugate vaccines through the investigation of conjugation chemistry Wang To investigate the genetics of pathogenesis of gram negative bacteria. M. catarrhalis is a model organism for these studies. To study the regulation of M. catarrhalis virulence gene expression and identify biomarkers for developing vaccine against M. catarrhalis.

7. 7/15 DBPAP regulatory/research portfolio Enteric and Sexually Transmitted Diseases (LESTD) Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

8. 8/15 Enteric and Sexually Transmitted Diseases (LESTD) Stibitz Molecular genetics of virulence and virulence-gene regulation in bacterial respiratory pathogens Kopecko Evaluate safety and utility of Salmonella typhi Ty21a as an oral vaccine delivery platform for expression of foreign antigens and delivery of anti-cancer therapies Analyze pathogenesis of and immune responses to Campylobacter jejuni infection in humans Evaluate the vaccine potential of inactivated enteric bacteria

9. 9/15 DBPAP regulatory/research portfolio Immunobiochemistry (LIB) Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

10. 10/15 DBPAP regulatory/research portfolio Mycobacterial Diseases and Cellular Immunology (LMDCI) Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

11. 11/15 Mycobacterial Diseases and Cellular Immunology (LMDCI) Elkins Understand innate immune responses to intracellular bacteria in general and LVS in particular, particularly facets with implications for safety and efficacy outcomes. Define mechanisms by which vaccine-induced immune T cells provide protection against intracellular bacteria, and thus establish practical immune correlates Morris Characterization of novel vaccines and immunization strategies against TB Development of assays to facilitate the assessment of TB vaccines Cowley Characterization of unique aspects of mucosal immune responses to intracellular pathogens. Malaria program – collaboration with OBRR

12. 12/15 DBPAP regulatory/research portfolio Respiratory and Special Pathogens (LRSP) Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

13. 13/15 Respiratory and Special Pathogens (LRSP) Arciniega Development and refinement of potency and toxicity tests for bacterial vaccines Burns Bacterial toxin structure/function relationships Study of host response to immunization with anthrax and Staphylococcal aureus vaccines Keller Clostridial neurotoxin vaccine and antitoxin research Merkel Development of animal aerosol challenge models for pertussis, anthrax and disease caused by Staphylococcus aureus. Analysis of gene regulation in Bordetella pertussis Schmitt Characterization of iron transport systems of Corynebacterium diphtheriae Analysis of gene regulation in C. diphtheriae

14. 14/15 Division of Bacterial, Parasitic and Allergenic Products (DBPAP Immediate Office of the Director Jay Slater, MD – Director Drusilla Burns, PhD – Deputy Director (Acting) Regulatory Staff Jennifer Bridgewater – Assoc. Dir. Regulatory Policy Tina Roecklein – Regulatory Coordinator 5 FTE Laboratory of Respiratory and Special Pathogens Drusilla Burns, PhD - Chief Juan Arciniega, D Sci James Keller, PhD Tod Merkel, PhD Michael Schmitt, PhD 16 FTE, 7 ORISE Laboratory of Bacterial Polysaccharides Willie Vann, PhD – Chief Mustafa Akkoyunlu, PhD Margaret Bash, MD Wei Wang, PhD John Cipollo, PhD Daron Freedberg, PhD 16 FTE, 11 ORISE Laboratory of Enteric and Sexually Transmitted Diseases Scott Stibitz, Ph.D. – Chief Dennis Kopecko, PhD 7 FTE, 13 ORISE Laboratory of Mycobacterial Diseases & Cellular Immunology Sheldon Morris, Ph.D. – Chief Siobhan Cowley, PhD Karen Elkins, PhD 10 FTE, 9 ORISE As of 15 April 2011 Laboratory of Immunobiochemisty Ron Rabin, M.D. – Chief 9 FTE, 7 ORISE

15. 15/15 LIB presenters Ronald Rabin, MD (2002) Ashraf El Fiky, MD PhD (2009) Jay E. Slater, MD (1998) Taruna Khurana, PhD (2009)